OTIS Autoimmune Diseases in Pregnancy Project
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Arthritis, Rheumatoid Arthritis, Infectious Disease, Gastrointestinal, Crohns Disease |
| Therapuetic Areas: | Gastroenterology, Immunology / Infectious Diseases, Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | November 2003 |
| End Date: | February 2017 |
Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
The purpose of the OTIS Autoimmune disease in pregnancy study is to monitor planned and
unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic
effect of these medications and to follow live born infants for one year after birth. With
respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be
relevant to a medication exposure during pregnancy, and these include both easily
recognizable defects that are visible at birth, as well as, more subtle or delayed defects
that may not be readily identifiable without special expertise and observation beyond the
newborn period.
unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic
effect of these medications and to follow live born infants for one year after birth. With
respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be
relevant to a medication exposure during pregnancy, and these include both easily
recognizable defects that are visible at birth, as well as, more subtle or delayed defects
that may not be readily identifiable without special expertise and observation beyond the
newborn period.
Inclusion Criteria:
- Currently pregnant
We found this trial at
1
site
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
Click here to add this to my saved trials
